In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth),...
Dr Turchin discusses the findings of his recent study, which identified predictors and consequences of declining insulin therapy among patients with type 2 diabetes. He also explains how endocrinologists...
In this podcast, Dr Lee discusses the current state of affairs with the COVID-19 pandemic, what the United States can learn from other countries with high rates of COVID-19 cases, and more.
In this podcast, Alexander Rothman, PhD, discusses his team's latest analysis of CANTOS, which evaluated whether interleukin-1β inhibition would reduce blood pressure, prevent incident...
In this podcast, Ryan Tedford, MD, answers our questions about his team's latest study, which assessed the impact of the new definition of pulmonary hypertension on heart transplant outcomes. Pulmonary...
In this podcast, Marisa McGinley, DO, answers our questions about how technology enables objective and standardized patient assessments in clinical practice, how the results of these assessments help...
In this podcast, Robert S. Rosenson, MD, from the Icahn School of Medicine at Mount Sinai in New York, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease...
In this podcast, Peter Libby, MD, from Brigham and Women’s Hospital and Harvard Medical School, gives an overview of clonal hematopoiesis of indeterminate potential, how it relates to cardiovascular...
